Related Experiment Videos
Both A type and B type Epstein-Barr virus nuclear antigen 6 interact with RBP-2N
D B Young1, K Krauer, N Kienzle
1Queensland Institute of Medical Research, EBV Unit, Bancroft Centre, Herston Queensland, Australia. davidY@qimr.edu.au
The Journal of General Virology
|July 1, 1997
Summary
Epstein-Barr virus nuclear antigen 6A (EBNA6A) interacts with RBP-J kappa
Area of Science:
- Virology
- Molecular Biology
- Cellular Biology
Background:
- Epstein-Barr virus (EBV) plays a role in various human diseases.
- EBV nuclear antigens (EBNAs) are key viral proteins involved in EBV pathogenesis.
- RBP-J kappa is a crucial transcription factor in cellular and viral gene regulation.
Purpose of the Study:
- To investigate the interaction between Epstein-Barr virus nuclear antigen 6A (EBNA6A) and the RBP-2N isoform of RBP-J kappa.
- To compare the binding efficiency of EBNA6A and EBNA6B with RBP-2N.
- To identify the specific domains involved in the EBNA6A-RBP-2N interaction.
Main Methods:
- Yeast two-hybrid system for protein-protein interaction studies.
- Deletion mutation analysis of EBNA6A to map interaction regions.
- Analysis of RBP-2N to identify binding domains for EBNA6A.
Main Results:
- EBNA6A directly interacts with the RBP-2N isoform of RBP-J kappa.
- EBNA6A exhibits a more efficient interaction with RBP-2N compared to EBNA6B.
- Specific regions within EBNA6A and RBP-2N were identified as critical for their interaction.
- The binding site on RBP-2N for EBNA6A overlaps with the known binding site for EBNA2.
Conclusions:
- EBNA6A binds to RBP-2N, suggesting a role in EBV-mediated transcriptional regulation.
- The differential binding affinities of EBNA6A and EBNA6B may influence their distinct functions in EBV infection.
- Understanding the EBNA6A-RBP-2N interaction provides insights into EBV oncogenesis and potential therapeutic targets.